Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

EMEA Setting Up Working Group To Aid Pharmacogenetics Field

April 2, 2003

By Peter O'Donnell

EMEA Setting Up Working Group To Aid Pharmacogenetics Field

April 2, 2003

By Peter O'Donnell

Report from Europe: Ethics advisors urge greater scrutiny of ads for genetic tests

April 1, 2003

By Peter O'Donnell

EU Leaders Continue To Express Support For Biotech - In Principle

March 26, 2003

By Peter O'Donnell

EU Leaders Continue To Express Support For Biotech - In Principle

March 26, 2003

By Peter O'Donnell

EU Worries More Biotechnology Companies Could Quit Europe

March 19, 2003

By Peter O'Donnell

EU Worries More Biotechnology Companies Could Quit Europe

March 19, 2003

By Peter O'Donnell

Action Still Trails Ambition In European Biotech Backing

March 12, 2003

By Peter O'Donnell

Action Still Trails Ambition In European Biotech Backing

March 12, 2003

By Peter O'Donnell

European Ethics Advisers Want Scrutiny In Area Of Genetic Tests

Feb. 26, 2003

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...